These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31599385)

  • 1. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma.
    Hol JC; van Oostendorp SE; Tuynman JB; Sietses C
    Tech Coloproctol; 2019 Sep; 23(9):903-911. PubMed ID: 31599385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer.
    Caycedo-Marulanda A; Lee L; Chadi SA; Verschoor CP; Crosina J; Ashamalla S; Brown CJ;
    JAMA Netw Open; 2021 Feb; 4(2):e2036330. PubMed ID: 33533932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
    Chen YT; Kiu KT; Yen MH; Chang TC
    Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results.
    Muratore A; Mellano A; Marsanic P; De Simone M
    Eur J Surg Oncol; 2015 Apr; 41(4):478-83. PubMed ID: 25633642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transanal total mesorectal excision: 3-year oncological outcomes.
    Ourô S; Albergaria D; Ferreira MP; Costeira B; Roquete P; Ferreira D; Maio R
    Tech Coloproctol; 2021 Feb; 25(2):205-213. PubMed ID: 33113009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients.
    Mege D; Hain E; Lakkis Z; Maggiori L; Prost À la Denise J; Panis Y
    Colorectal Dis; 2018 Jun; 20(6):O143-O151. PubMed ID: 29693307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal mesorectal excision: early outcomes in Australia and New Zealand.
    Lau S; Kong J; Bell S; Heriot A; Stevenson A; Moloney J; Hayes J; Merrie A; Eglinton T; Guest G; Clark D; Warrier S
    Br J Surg; 2021 Mar; 108(2):214-219. PubMed ID: 33711138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer.
    Dittrich L; Biebl M; Schmuck R; Gül S; Weiss S; Haase O; Knoop M; Alkatout I; Pratschke J; Aigner F
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33379270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries.
    Perdawood SK; Thinggaard BS; Bjoern MX
    Surg Endosc; 2018 May; 32(5):2312-2321. PubMed ID: 29098433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 18. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients.
    Burke JP; Martin-Perez B; Khan A; Nassif G; de Beche-Adams T; Larach SW; Albert MR; Atallah S
    Colorectal Dis; 2016 Jun; 18(6):570-7. PubMed ID: 26749148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
    Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
    Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.
    González-Abós C; de Lacy FB; Guzmán Y; Nogueira ST; Otero-Piñeiro A; Almenara R; Lacy AM
    Surg Endosc; 2021 Dec; 35(12):7191-7199. PubMed ID: 33398553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.